GO:0045660 positive regulation of neutrophil differentiation: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0045660 (positive regulation of neutrophil differentiation) is a biological process term defined as any process that activates or increases the frequency, rate or extent of neutrophil differentiation.
• Neutrophil differentiation is a tightly controlled transcriptional program that converts myeloid progenitors into mature, functional neutrophils.
• Positive regulators of this process include lineage-determining transcription factors, cytokine signaling pathways, and chromatin remodeling complexes that enforce the neutrophil fate.
• Dysregulation of positive regulation of neutrophil differentiation contributes to cancer immunosuppression, chronic inflammation, and impaired host defense.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of genes that positively regulate neutrophil differentiation.
• Understanding this GO term supports development of therapies that modulate neutrophil production in infection, autoimmunity, and malignancy.
Description
GO:0045660, positive regulation of neutrophil differentiation, is a Gene Ontology biological process term that describes any process that activates or increases the frequency, rate or extent of neutrophil differentiation. Neutrophils are the most abundant circulating leukocytes and serve as first responders to infection and inflammation. Their differentiation from myeloid progenitors is a highly regulated process that must be precisely controlled to maintain immune homeostasis. The positive regulation of this process ensures adequate neutrophil supply during steady-state hematopoiesis and in response to stress or infection. Research into positive regulation of neutrophil differentiation is important because perturbations in this process are linked to diverse pathologies. For example, tumors can reprogram neutrophil differentiation toward immunosuppressive states, as shown in breast cancer where ferroptotic neutrophils induce immunosuppression and chemoresistance. In non-alcoholic steatohepatitis, interactions between regulatory T cells and neutrophil extracellular traps contribute to carcinogenesis, highlighting the importance of neutrophil regulation in chronic liver disease. Additionally, the microbiome regulates neutrophil ageing, indicating that environmental factors influence neutrophil life cycle and function. Understanding the molecular players that positively regulate neutrophil differentiation provides opportunities for therapeutic intervention. Key transcription factors, cytokines such as IL-17A and IL-1, and signaling pathways including WNT and platelet-activating factor (PAF) have been implicated in modulating neutrophil differentiation and function. Chromatin-state barriers also enforce irreversible cell fate decisions during differentiation, underscoring the role of epigenetic regulation. This article synthesizes current knowledge on GO:0045660, its mechanisms, associated genes, disease relevance, and research methodologies, with a focus on CRISPR-based approaches for functional validation.
positive regulation of neutrophil differentiation At A Glance
| GO ID | GO:0045660 |
|---|---|
| GO term | positive regulation of neutrophil differentiation |
| Ontology | biological_process |
| Synonym | activation of neutrophil differentiation, stimulation of neutrophil differentiation, up regulation of neutrophil differentiation, up-regulation of neutrophil differentiation, upregulation of neutrophil differentiation |
| Major function | Promotes the differentiation of myeloid progenitors into mature neutrophils |
| Related biological process | Myeloid cell differentiation, granulocyte differentiation, hematopoiesis |
| Cellular context | Bone marrow, hematopoietic niches, inflammatory sites |
| Key regulators | Transcription factors (e.g., CEBPE, SPI1), cytokines (e.g., G-CSF, IL-17A), signaling pathways (e.g., WNT, PAF) |
| Disease relevance | Cancer, chronic inflammation, autoimmune diseases, infections |
What Is GO:0045660?
According to the Gene Ontology, GO:0045660 (positive regulation of neutrophil differentiation) is defined as any process that activates or increases the frequency, rate or extent of neutrophil differentiation. This term encompasses molecular events that promote the transition of myeloid progenitor cells into mature neutrophils, including transcriptional activation of neutrophil-specific genes, cytokine-mediated signaling, and epigenetic changes that favor the neutrophil lineage. It is a child of the broader terms 'regulation of neutrophil differentiation' and 'positive regulation of myeloid cell differentiation'.
Why Is positive regulation of neutrophil differentiation Important in Cell Biology?
Positive regulation of neutrophil differentiation is critical for maintaining adequate neutrophil numbers and function, which are essential for innate immunity. Dysregulation can lead to neutropenia or neutrophilia, contributing to increased susceptibility to infections or inflammatory tissue damage. Moreover, tumors can hijack this process to generate immunosuppressive neutrophils that promote cancer progression and therapy resistance. Understanding the positive regulators of neutrophil differentiation therefore has broad implications for immunology, cancer biology, and therapeutic development.
• Ensures sufficient production of mature neutrophils for host defense against pathogens.
• Dysregulation contributes to neutropenia, increasing infection risk.
• Tumor-derived factors can promote immunosuppressive neutrophil differentiation, aiding cancer immune evasion.
• Chronic inflammation conditions such as non-alcoholic steatohepatitis involve aberrant neutrophil regulation.
• Microbiome signals influence neutrophil ageing and potentially differentiation.
• Cytokines like IL-17A and IL-1 modulate neutrophil differentiation and function.
• Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors.
• Chromatin-state barriers enforce irreversible cell fate decisions, including neutrophil differentiation.
• Targeting positive regulators may offer therapeutic strategies for inflammatory diseases and cancer.
• CRISPR screens can identify novel positive regulators of neutrophil differentiation.
What Happens During positive regulation of neutrophil differentiation?
Initiation of Neutrophil Differentiation
In simple terms: The process starts when stem cells receive signals to become neutrophils.
Positive regulation of neutrophil differentiation begins with the activation of lineage-specific transcription factors in hematopoietic stem and progenitor cells. Key transcription factors such as SPI1 (PU.1) and CEBPA prime the myeloid lineage, while CEBPE is crucial for terminal neutrophil differentiation. Cytokines such as granulocyte colony-stimulating factor (G-CSF) and interleukin-17A (IL-17A) provide external signals that promote differentiation. These signals activate downstream pathways that drive the expression of neutrophil-specific genes.
Transcriptional Control of Neutrophil Fate
In simple terms: Specific proteins turn on genes that make a cell become a neutrophil.
Transcriptional regulation is central to positive regulation of neutrophil differentiation. The transcription factor CEBPE acts as a master regulator of terminal neutrophil differentiation, controlling genes involved in granule formation and respiratory burst. Other factors, such as GFI1 and KLF4, also modulate this process. Chromatin remodeling complexes, including the SWI/SNF complex, facilitate access to neutrophil-specific gene loci, and chromatin-state barriers ensure irreversible commitment to the neutrophil lineage.
Cytokine and Signaling Pathways
In simple terms: External signals like cytokines tell cells to become neutrophils.
Cytokines and growth factors positively regulate neutrophil differentiation. IL-17A, a pro-inflammatory cytokine, promotes granulopoiesis and neutrophil differentiation. IL-1 signaling, in conjunction with WNT pathways, regulates dermal adipocyte lineage cells and may influence neutrophil differentiation in inflammatory contexts. Platelet-activating factor (PAF) has been shown to promote immunosuppressive neutrophil differentiation within tumors, highlighting the role of lipid mediators. These pathways converge on transcription factors to enhance neutrophil gene expression.
Epigenetic and Microenvironmental Influences
In simple terms: The environment and chemical tags on DNA affect how cells become neutrophils.
Epigenetic modifications and the bone marrow microenvironment positively regulate neutrophil differentiation. The microbiome influences neutrophil ageing, suggesting that microbial signals can modulate neutrophil life cycle. Chromatin-state barriers enforce irreversible cell fate decisions, meaning that once a cell commits to the neutrophil lineage, it cannot easily revert. These epigenetic mechanisms ensure robust and stable neutrophil differentiation.
Key Genes Involved in GO:0045660 positive regulation of neutrophil differentiation
The following genes and proteins have been implicated in positively regulating neutrophil differentiation, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CEBPE | Master transcription factor for terminal neutrophil differentiation | Knockout leads to neutrophil-specific granule deficiency |
| SPI1 (PU.1) | Myeloid lineage determination | Essential for early myeloid differentiation |
| CEBPA | Myeloid lineage commitment | Cooperates with SPI1 to drive granulopoiesis |
| G-CSF | Cytokine that stimulates neutrophil production | Used clinically to treat neutropenia |
| IL17A | Pro-inflammatory cytokine promoting granulopoiesis | Linked to autoimmune diseases and cancer |
| IL1B | Cytokine influencing differentiation in inflammatory contexts | Interplay with WNT pathways in skin and wound healing |
| WNT | Signaling pathway regulating cell fate decisions | Modulates dermal adipocyte lineage and potentially neutrophil differentiation |
| PAF | Lipid mediator promoting immunosuppressive neutrophil differentiation | Tumor microenvironment factor |
| GFI1 | Transcriptional repressor regulating granulopoiesis | Mutations cause severe congenital neutropenia |
| KLF4 | Transcription factor modulating myeloid differentiation | Involved in monocyte and neutrophil development |
| CSF3R | Receptor for G-CSF | Mutations cause severe congenital neutropenia |
| RUNX1 | Transcription factor in hematopoiesis | Required for definitive hematopoiesis |
| LYN | Kinase modulating cytokine signaling | Regulates neutrophil differentiation and function |
| JAK2 | Kinase in cytokine signaling pathways | Mediates G-CSF signaling |
| STAT3 | Transcription factor downstream of cytokines | Promotes neutrophil differentiation |
| CEBPB | Transcription factor in emergency granulopoiesis | Induced by inflammatory signals |
| SWI/SNF complex | Chromatin remodeling | Facilitates access to neutrophil-specific genes |
How Is positive regulation of neutrophil differentiation Regulated?
Positive regulation of neutrophil differentiation is controlled by a network of transcription factors, cytokines, and epigenetic modifiers. Key transcription factors such as CEBPE, SPI1, and CEBPA form a regulatory circuit that reinforces the neutrophil fate. Cytokine signaling through G-CSF, IL-17A, and IL-1 activates JAK-STAT and other pathways to promote differentiation. Chromatin remodeling complexes and histone modifications establish an open chromatin state at neutrophil-specific loci, while barriers prevent reversal of the differentiated state. Additionally, the microbiome and inflammatory microenvironment provide external cues that modulate neutrophil differentiation and ageing.
positive regulation of neutrophil differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CEBPE | Neutrophil-specific granule deficiency | Knockout mouse, patient-derived iPSCs |
| GFI1 | Severe congenital neutropenia | Knock-in mouse with patient mutations |
| CSF3R | Severe congenital neutropenia, myeloid malignancies | Point-mutation knock-in in hematopoietic stem cells |
| IL17A | Autoimmune diseases, cancer | Overexpression or knockout mouse models |
| PAF | Tumor immunosuppression | Xenograft models with PAF receptor knockout |
Cancer and Immunosuppression
Tumors can hijack positive regulation of neutrophil differentiation to generate immunosuppressive neutrophils. In breast cancer, ferroptotic neutrophils induce immunosuppression and chemoresistance, highlighting a role for aberrant neutrophil differentiation in therapy resistance. Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors, suggesting that targeting PAF signaling could reverse immunosuppression. These findings indicate that positive regulators of neutrophil differentiation are potential therapeutic targets in cancer.
Chronic Inflammation and Liver Disease
In non-alcoholic steatohepatitis (NASH), interactions between regulatory T cells and neutrophil extracellular traps contribute to carcinogenesis, linking neutrophil regulation to chronic liver disease progression. IL-17A, a positive regulator of neutrophil differentiation, is implicated in various inflammatory diseases, including psoriasis and inflammatory bowel disease. Thus, dysregulated positive regulation of neutrophil differentiation can exacerbate inflammatory pathology.
Infections and Neutropenia
Impaired positive regulation of neutrophil differentiation leads to neutropenia, characterized by low neutrophil counts and increased susceptibility to bacterial and fungal infections. Mutations in genes such as GFI1, CSF3R, and CEBPE cause severe congenital neutropenia, underscoring the clinical importance of this process. Understanding the positive regulators can inform treatments to boost neutrophil production in neutropenic patients.
From positive regulation of neutrophil differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate neutrophil differentiation? | CRISPR knockout in HL-60 or NB4 cell lines, followed by differentiation assays |
| What is the effect of a specific point mutation in gene Y on neutrophil differentiation? | CRISPR point-mutation knock-in in primary hematopoietic stem cells |
| How does overexpression of gene Z affect neutrophil differentiation? | Lentiviral overexpression in myeloid progenitor cells |
| What is the role of chromatin remodeling in neutrophil differentiation? | Knockout of SWI/SNF subunits in hematopoietic stem cells |
| How do cytokines like IL-17A modulate neutrophil differentiation? | Knockout of IL17A or its receptor in mouse models |
| Can CRISPR screening identify novel positive regulators? | Genome-wide CRISPR knockout screen in a neutrophil differentiation model |
How to Study the positive regulation of neutrophil differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Loss-of-function phenotypes for all genes | Identify novel positive regulators of neutrophil differentiation |
| RNA-seq | Transcriptome changes | Compare gene expression between wild-type and mutant cells |
| Flow cytometry | Surface marker expression | Quantify differentiation efficiency |
| ATAC-seq | Chromatin accessibility | Assess epigenetic changes during differentiation |
| Proteomics | Protein abundance and modifications | Identify signaling pathways involved |
| Immunoblotting | Protein expression and phosphorylation | Validate specific pathway activation |
| Cytokine assays | Secreted factor levels | Measure inflammatory mediators |
| In vivo mouse models | Neutrophil counts and function | Test gene function in hematopoiesis |
CRISPR Knockout Screening
Genome-wide CRISPR knockout screens can identify genes that positively regulate neutrophil differentiation. By introducing a library of guide RNAs into myeloid progenitor cells and inducing differentiation, researchers can select for cells that fail to differentiate and identify enriched sgRNAs targeting candidate positive regulators.
Transcriptomic Profiling
RNA sequencing (RNA-seq) of differentiating neutrophils at various time points reveals dynamic changes in gene expression. Comparing wild-type and knockout cells can pinpoint pathways controlled by positive regulators of neutrophil differentiation.
Flow Cytometry and Imaging
Flow cytometry using surface markers (e.g., CD11b, CD16) and morphological imaging can quantify neutrophil differentiation. These methods are essential for validating CRISPR-induced phenotypes and assessing the impact of genetic perturbations.
Proteomics and Epigenomics
Mass spectrometry-based proteomics and ATAC-seq can uncover protein-level changes and chromatin accessibility dynamics during neutrophil differentiation. These approaches help define the molecular mechanisms by which positive regulators act.
How CRISPR Can Be Used to Study GO:0045660 positive regulation of neutrophil differentiation
Knockout
CRISPR knockout is used to completely ablate candidate positive regulators of neutrophil differentiation. For example, knocking out CEBPE in myeloid cell lines results in a block in terminal differentiation, confirming its essential role. Genome-wide knockout screens can systematically identify all genes required for this process.
Point Mutation
CRISPR point mutation allows introduction of specific disease-associated mutations. For instance, knock-in of GFI1 mutations found in severe congenital neutropenia can model the disease and reveal how these mutations impair positive regulation of neutrophil differentiation.
Knock-in
Knock-in of reporter genes or epitope tags enables tracking of differentiation markers. Tagging endogenous CEBPE with fluorescent proteins allows live imaging of neutrophil differentiation in real time.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can force expression of candidate positive regulators. Overexpressing IL17A or PAF receptor in progenitor cells can enhance neutrophil differentiation and promote immunosuppressive phenotypes.
How EDITGENE Supports positive regulation of neutrophil differentiation Research
Researchers studying positive regulation of neutrophil differentiation-related genes often need to determine whether a candidate gene is causally involved in driving or modulating this process. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such functional studies, from gene knockout to precise point mutations and overexpression, along with library screening and bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of neutrophil differentiation research.
Frequently Asked Questions About positive regulation of neutrophil differentiation
What is GO:0045660?
GO:0045660 is the Gene Ontology term for positive regulation of neutrophil differentiation, defined as any process that activates or increases the frequency, rate or extent of neutrophil differentiation.
What genes are involved in positive regulation of neutrophil differentiation?
Key genes include CEBPE, SPI1, CEBPA, GFI1, CSF3R, IL17A, and components of the WNT and PAF signaling pathways.
How is positive regulation of neutrophil differentiation studied?
Researchers use CRISPR knockout screens, RNA-seq, flow cytometry, and proteomics to study this process.
Why is positive regulation of neutrophil differentiation important in cancer?
Tumors can promote immunosuppressive neutrophil differentiation, which contributes to immune evasion and chemoresistance.
What diseases are associated with dysregulated neutrophil differentiation?
Diseases include severe congenital neutropenia, non-alcoholic steatohepatitis, and various cancers.
Can CRISPR be used to study positive regulation of neutrophil differentiation?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting gene function in this process.
What is the role of IL-17A in neutrophil differentiation?
IL-17A is a pro-inflammatory cytokine that promotes granulopoiesis and neutrophil differentiation.
How does the microbiome affect neutrophil differentiation?
The microbiome regulates neutrophil ageing, suggesting it can influence neutrophil life cycle and potentially differentiation.
What is the connection between PAF and neutrophil differentiation?
Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors.
What experimental models are available for studying neutrophil differentiation?
Models include HL-60 and NB4 cell lines, primary hematopoietic stem cells, and genetically modified mouse models.
Conclusion
GO:0045660, positive regulation of neutrophil differentiation, is a fundamental biological process that ensures adequate production of neutrophils for immune defense. Its dysregulation is implicated in cancer, chronic inflammation, and neutropenia. Advances in CRISPR technology have enabled precise functional studies of the genes and pathways that positively regulate this process, offering potential therapeutic targets. Continued research into the molecular mechanisms and disease relevance of this GO term will likely yield new insights and interventions.
References
- 1. Zeng W et al.. 2025. Ferroptotic Neutrophils Induce Immunosuppression and Chemoresistance in Breast Cancer.. Cancer Res 85(3):477-496 PMID: 39531510
- 2. Wang H et al.. 2021. Regulatory T-cell and neutrophil extracellular trap interaction contributes to carcinogenesis in non-alcoholic steatohepatitis.. J Hepatol 75(6):1271-1283 PMID: 34363921
- 3. Zhang D et al.. 2015. Neutrophil ageing is regulated by the microbiome.. Nature 525(7570):528-32 PMID: 26374999
- 4. Chen K et al.. 2017. Interluekin-17A (IL17A).. Gene 614:8-14 PMID: 28122268
- 5. Sun L et al.. 2023. Dynamic interplay between IL-1 and WNT pathways in regulating dermal adipocyte lineage cells during skin development and wound regeneration.. Cell Rep 42(6):112647 PMID: 37330908
- 6. Berliner N. 1998. Molecular biology of neutrophil differentiation.. Curr Opin Hematol 5(1):49-53 PMID: 9515203
- 7. Dahal A et al.. 2024. Platelet-activating factor (PAF) promotes immunosuppressive neutrophil differentiation within tumors.. Proc Natl Acad Sci U S A 121(35):e2406748121 PMID: 39178229
- 8. Blanco MA et al.. 2021. Chromatin-state barriers enforce an irreversible mammalian cell fate decision.. Cell Rep 37(6):109967 PMID: 34758323
